Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GULDSMED ANDERS MØRCK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6%   Bankruptcy risk   2.2% 1.6% 1.5% 2.5% 1.5% 1.2% 14.7% 14.7%   Credit score (0-100)   67 76 77 61 76 80 14 14   Credit rating   BBB A A BBB A A BB BB   Credit limit (kDKK)   0.0 2.0 4.7 0.0 4.3 23.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,041 1,139 1,215 1,327 1,250 1,306 0.0 0.0   EBITDA   111 174 204 112 264 336 0.0 0.0   EBIT   53.9 117 185 52.4 204 276 0.0 0.0   Pre-tax profit (PTP)   45.6 109.9 177.7 45.2 196.3 273.4 0.0 0.0   Net earnings   35.5 86.4 138.5 34.6 152.5 212.4 0.0 0.0   Pre-tax profit without non-rec. items   45.6 110 178 45.2 196 273 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   172 115 240 180 120 60.0 0.0 0.0   Shareholders equity total   543 522 549 471 566 661 334 334   Interest-bearing liabilities   157 110 208 163 121 75.0 0.0 0.0   Balance sheet total (assets)   1,070 1,050 1,124 1,059 1,085 1,188 334 334   Net Debt   -150 -209 -34.5 -0.2 -71.5 -114 -334 -334     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,041 1,139 1,215 1,327 1,250 1,306 0.0 0.0   Gross profit growth   -5.6% 9.4% 6.7% 9.2% -5.8% 4.5% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,070 1,050 1,124 1,059 1,085 1,188 334 334   Balance sheet change%   -8.5% -1.9% 7.1% -5.8% 2.5% 9.5% -71.9% 0.0%   Added value   111.2 174.1 204.4 112.4 264.5 335.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -115 -115 106 -120 -120 -120 -60 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.2% 10.3% 15.2% 3.9% 16.4% 21.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.8% 11.0% 17.0% 4.8% 19.1% 24.3% 0.0% 0.0%   ROI %   7.1% 17.5% 26.5% 7.5% 30.8% 38.7% 0.0% 0.0%   ROE %   6.1% 16.2% 25.9% 6.8% 29.4% 34.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   50.7% 49.7% 48.9% 44.5% 52.2% 55.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -135.3% -120.3% -16.9% -0.2% -27.0% -34.0% 0.0% 0.0%   Gearing %   29.0% 21.0% 37.9% 34.7% 21.4% 11.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.6% 5.2% 4.5% 3.9% 5.8% 2.4% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.7 0.7 0.5 0.3 0.5 0.5 0.0 0.0   Current Ratio   1.7 1.8 1.6 1.5 1.9 2.1 0.0 0.0   Cash and cash equivalent   307.8 319.1 242.6 163.6 192.9 189.2 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   374.7 406.9 315.2 295.3 446.4 600.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   56 87 102 56 132 168 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   56 87 102 56 132 168 0 0   EBIT / employee   27 58 92 26 102 138 0 0   Net earnings / employee   18 43 69 17 76 106 0 0